{"id":"cd69ffe0-5c3c-5752-a8b4-81ca367b3ecd","stable_key":"d39c4b36-9a88-5f52-8e6b-93a248dc4bfc:hericenones-erinacines-hericenone-e-ngf","predicate":"partially_blocks","statement":"K252a partially blocked hericenone-E-associated neuritogenesis, while hericenone E increased NGF secretion and ERK/Akt phosphorylation.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"a818963f-6938-50fc-9e62-2631baaaf983","mechanism_event_label":"K252a partially blocked hericenone-E-associated neuritogenesis, while hericenone E increased NGF secretion and ERK/Akt phosphorylation.","subject":{"id":"1de5c137-5e43-546b-a8e0-55995c895179","slug":"k252a","display_name":"K252a Trk-family inhibitor","entity_type_key":"drug"},"object":{"id":"9301af4f-dfd4-5499-8868-854b0e0a9dfd","slug":"hericenone-e-ngf-neuritogenesis","display_name":"Hericenone E potentiation of NGF-induced PC12 neuritogenesis","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"a818963f-6938-50fc-9e62-2631baaaf983","stable_key":"d39c4b36-9a88-5f52-8e6b-93a248dc4bfc:hericenones-erinacines-hericenone-e-ngf-event","event_type":"observed_relationship","label":"K252a partially blocked hericenone-E-associated neuritogenesis, while hericenone E increased NGF secretion and ERK/Akt phosphorylation.","description":"K252a partially blocked hericenone-E-associated neuritogenesis, while hericenone E increased NGF secretion and ERK/Akt phosphorylation.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"1de5c137-5e43-546b-a8e0-55995c895179","slug":"k252a","display_name":"K252a Trk-family inhibitor","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"9301af4f-dfd4-5499-8868-854b0e0a9dfd","slug":"hericenone-e-ngf-neuritogenesis","display_name":"Hericenone E potentiation of NGF-induced PC12 neuritogenesis","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"e6b83acb-bf46-5777-a085-02025da533a8","slug":"hericenone-e","display_name":"Hericenone E","entity_type_key":"small_molecule"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"05f59de8-50e8-5e30-b0b2-3b5812b022f7","slug":"human-ngf","display_name":"Human nerve growth factor / NGF","entity_type_key":"protein"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"2944ff54-7d74-5b34-bc0c-c77ac1444717","slug":"erk1-2","display_name":"ERK1/2 proteins, isoform not resolved","entity_type_key":"protein_family"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"a13cb592-c939-5f92-9206-d774248802fc","slug":"akt-proteins","display_name":"AKT serine/threonine kinase family","entity_type_key":"protein_family"},"role":"context_participant","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"dose","value_text":"Hericenone E with low NGF and K252a","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"duration","value_text":"Differentiation assay","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_scope","value_text":"literature_reviewed; model-specific source-derived curation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Rat PC12 pheochromocytoma cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Partial blockade suggests Trk involvement but not sole dependence; PC12 exposure does not establish human brain target engagement.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hericenones & Erinacines chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hericenones-erinacines","display_name":"Hericenones and erinacines","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Rat PC12 pheochromocytoma cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"K252a partially blocked hericenone-E-associated neuritogenesis, while hericenone E increased NGF secretion and ERK/Akt phosphorylation.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways. (2014). https://pubmed.ncbi.nlm.nih.gov/25288148/ DOI: 10.1039/c4fo00452c","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vitro","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"NGF secretion, neurite outgrowth, ERK and Akt","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"e39341af-8d76-5ff5-819a-f25d619492eb","evidence_kind":"source_excerpt","locator":"Lines 44-53","start_line":44,"end_line":53,"excerpt":"## hericenones-erinacines-hericenone-e-ngf\nK252a partially blocked hericenone-E-associated neuritogenesis, while hericenone E increased NGF secretion and ERK/Akt phosphorylation.\nModel/species: Rat PC12 pheochromocytoma cells\nTissue/system: NGF secretion, neurite outgrowth, ERK and Akt\nExposure: Hericenone E with low NGF and K252a\nRoute: In vitro\nDuration: Differentiation assay\nLimits: Partial blockade suggests Trk involvement but not sole dependence; PC12 exposure does not establish human brain target engagement.\nPrimary reference: Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways. (2014). https://pubmed.ncbi.nlm.nih.gov/25288148/ DOI: 10.1039/c4fo00452c\nAccess: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","model_system":"Rat PC12 pheochromocytoma cells","directness":"reported_statement","verification_status":"source_derived_draft","notes":"Exact original curation span with primary citation; not a publisher quotation.","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"aa7c09fd-ab4a-51ff-b463-d35547dc41ba","stable_key":"import-d39c4b36-9a88-5f52-8e6b-93a248dc4bfc","title":"Hericenones & Erinacines: mechanism of action and interactions (2026-09-20)","document_type":"imported_text","citation_label":"Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text.","file_path":"","sha256":"f1ff2966f222f5c463e8e509ec1b1642a0053cd38f121f3847cdd21855c46e85","revision_id":"d00076e0-da87-5100-92ed-0525190b25a1","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}